SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. 1993a. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol 11(1): 17.
  • Adcock IM, Peters MJ, Brown CR, Gelder CM, Barnes PJ. 1993b. Transcription factor interactions in human lung. Biochem Soc Trans 21(Pt 3): 277S.
  • Agro A, Stanisz AM. 1993. Inhibition of murine intestinal inflammation by anti-substance P antibody. Reg Immunol 5(2): 120126.
  • Ansel JC, Brown JR, Payan DG, Brown MA. 1993. Substance P selectively activates TNF-alpha gene expression in murine mast cells. J Immunol 150(10): 44784485.
  • Bai TR, Zhou D, Weir T, Walker B, Hegele R, Hayashi S, McKay K, Bondy GP, Fong T. 1995. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am J Physiol 269(3 Pt 1): L309L317.
  • Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA. 1995. NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 268(2 Pt 1): L263L269.
  • Baluk P, Bertrand C, Geppetti P, McDonald DM, Nadel JA. 1996. NK1 receptor antagonist CP-99,994 inhibits cigarette smoke-induced neutrophil and eosinophil adhesion in rat tracheal venules. Exp Lung Res 22(4): 409418.
  • Bang R, Biburger M, Neuhuber WL, Tiegs G. 2004. Neurokinin-receptor antagonists protect mice from CD95- and TNF{alpha}-mediated apoptotic liver damage. J Pharmacol Exp Ther 308: 926934.
  • Bar-Shavit Z, Goldman R, Stabinsky Y, Gottlieb P, Fridkin M, Teichberg VI, Blumberg S. 1980. Enhancement of phagocytosis—a newly found activity of substance P residing in its N-terminal tetrapeptide sequence. Biochem Biophys Res Commun 94(4): 14451451.
  • Barnes PJ, Baraniuk JN, Belvisi MG. 1991. Neuropeptides in the respiratory tract. Part I. Am Rev Respir Dis 144(5): 11871198.
  • Ben-Jebria A, Marthan R, Rossetti M, Savineau JP. 1993. Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A, and VIP. Br J Pharmacol 109(1): 131136.
  • Bepler G, Rotsch M, Jaques G, Haeder M, Heymanns J, Hartogh G, Kiefer P, Havemann K. 1988. Peptides and growth factors in small cell lung cancer: Production, binding sites, and growth effects. J Cancer Res Clin Oncol 114(3): 235244.
  • Bernstein CN, Vidrich A. 1994. Isolation, identification, and culture of normal mouse colonic glia. Glia 12(2): 108116.
  • Bernstein CN, Robert ME, Eysselein VE. 1993. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am J Gastroenterol 88(6): 908913.
  • Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, Wang CC, Gerard N, Pothoulakis C, Steer ML. 1998. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci USA 95(8): 47604765.
  • Bill A, Stjernschantz J, Mandahl A, Brodin E, Nilsson G. 1979. Substance P: Release on trigeminal nerve stimulation, effects in the eye. Acta Physiol Scand 106(3): 371373.
  • Blackshaw LA, Dent J. 1997. Lower oesophageal sphincter responses to noxious oesophageal chemical stimuli in the ferret: Involvement of tachykinin receptors. J Auton Nerv Syst 66(3): 189200.
  • Bockmann S, Seep J, Jonas L. 2001. Delay of neutrophil apoptosis by the neuropeptide substance P: Involvement of caspase cascade. Peptides 22(4): 661670.
  • Borson DB. 1991. Roles of neutral endopeptidase in airways. Am J Physiol 260(4 Pt 1): L212L225.
  • Bost KL, Pascual DW. 1992. Substance P: A late-acting B lymphocyte differentiation cofactor. Am J Physiol 262(3 Pt 1): C537C545.
  • Bost KL, Breeding SA, Pascual DW. 1992. Modulation of the mRNAs encoding substance P and its receptor in rat macrophages by LPS. Reg Immunol 4(2): 105112.
  • Bozic CR, Lu B, Hopken UE, Gerard C, Gerard NP. 1996. Neurogenic amplification of immune complex inflammation. Science 273(5282): 17221725.
  • Braunstein G, Fajac I, Lacronique J, Frossard N. 1991. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Respir Dis 144(3 Pt 1): 630635.
  • Brunelleschi S, Nicali R, Lavagno L, Viano I, Pozzi E, Gagliardi L, Ghio P, Albera C. 2000. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers, or healthy volunteers. Neuropeptides 34(1): 4550.
  • Calvo CF, Chavanel G, Senik A. 1992. Substance P enhances IL-2 expression in activated human T cells. J Immunol 148(11): 34983504.
  • Carr MJ, Hunter DD, Jacoby DB, Undem BJ. 2002. Expression of tachykinins in nonnociceptive vagal afferent neurons during respiratory viral infection in guinea pigs. Am J Respir Crit Care Med 165(8): 10711075.
  • Castagliuolo I, Keates AC, Qiu B, Kelly CP, Nikulasson S, Leeman SE, Pothoulakis C. 1997. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci USA 94(9): 47884793.
  • Castagliuolo I, Riegler M, Pasha A, Nikulasson S, Lu B, Gerard C, Gerard NP, Pothoulakis C. 1998. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile-induced enteritis. J Clin Invest 101(8): 15471550.
  • Castro-Obregon S, Del Rio G, Chen SF, Swanson RA, Frankowski H, Rao RV, Stoka V, Vesce S, Nicholls DG, Bredesen DE. 2002. A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ 9(8): 807817.
  • Chang MM, Leeman SE, Niall HD. 1971. Amino-acid sequence of substance P. Nat New Biol 232(29): 8687.
  • Chang FY, Lee SD, Yeh GH, Wang PS. 1999. Rat gastrointestinal motor responses mediated via activation of neurokinin receptors. J Gastroenterol Hepatol 14(1): 3945.
  • Cheung D, Timmers MC, Zwinderman AH, den Hartigh J, Dijkman JH, Sterk PJ. 1993. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo. Am Rev Respir Dis 148(6 Pt 1): 14671473.
  • Cheung D, van der Veen H, den Hartigh J, Dijkman JH, Sterk PJ. 1994. Effects of inhaled substance P on airway responsiveness to methacholine in asthmatic subjects in vivo. J Appl Physiol 77(3): 13251332.
  • Chu HW, Kraft M, Krause JE, Rex MD, Martin RJ. 2000. Substance P and its receptor neurokinin 1 expression in asthmatic airways. J Allergy Clin Immunol 106(4): 713722.
  • Chung KF, Chang AB. 2002. Therapy for cough: Active agents. Pulm Pharmacol Ther 15(3): 335338.
  • Colpaert FC, Donnerer J, Lembeck F. 1983. Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. Life Sci 32(16): 18271834.
  • Colten HR, Krause JE. 1997. Pulmonary inflammation—a balancing act. N Engl J Med 336(15): 10941096.
  • Corboz MR, Rivelli MA, Ramos SI, Rizzo CA, Hey JA. 1998. Tachykinin NK1 receptor-mediated vasorelaxation in human pulmonary arteries. Eur J Pharmacol 350(1): R1R3.
  • Covas MJ, Pinto LA, Victorino RM. 1994. Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection. Clin Exp Immunol 96(3): 384388.
  • Crimi N, Palermo F, Oliveri R, Palermo B, Vancheri C, Polosa R, Mistretta A. 1990. Influence of antihistamine (astemizole) and anticholinergic drugs (ipratropium bromide) on bronchoconstriction induced by substance P. Ann Allergy 65(2): 115120.
  • Croitoru K, Ernst PB, Bienenstock J, Padol I, Stanisz AM. 1990. Selective modulation of the natural killer activity of murine intestinal intraepithelial leucocytes by the neuropeptide substance P. Immunology 71(2): 196201.
  • DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW. 2000. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97(20): 1108611091.
  • DeRose V, Robbins RA, Snider RM, Spurzem JR, Thiele GM, Rennard SI, Rubinstein I. 1994. Substance P increases neutrophil adhesion to bronchial epithelial cells. J Immunol 152(3): 13391346.
  • Di Sebastiano P, di Mola FF, Di Febbo C, Baccante G, Porreca E, Innocenti P, Friess H, Buchler MW. 2000. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 47(3): 423428.
  • Dimri R, Sharabi Y, Shoham J. 2000. Specific inhibition of glucocorticoid-induced thymocyte apoptosis by substance P. J Immunol 164(5): 24792486.
  • Donaldson LF, Haskell CA, Hanley MR. 2001. Messenger RNA localization and further characterisation of the putative tachykinin receptor NK4 (NK3B). Receptors Channels 7(4): 259272.
  • Dusser DJ, Djokic TD, Borson DB, Nadel JA. 1989. Cigarette smoke induces bronchoconstrictor hyperresponsiveness to substance P and inactivates airway neutral endopeptidase in the guinea pig. Possible role of free radicals. J Clin Invest 84(3): 900906.
  • Eglezos A, Andrews PV, Boyd RL, Helme RD. 1990. Effects of capsaicin treatment on immunoglobulin secretion in the rat: Further evidence for involvement of tachykinin-containing afferent nerves. J Neuroimmunol 26(2): 131138.
  • Epperson A, Hatton WJ, Callaghan B, Doherty P, Walker RL, Sanders KM, Ward SM, Horowitz B. 2000. Molecular markers expressed in cultured and freshly isolated interstitial cells of Cajal. Am J Physiol Cell Physiol 279(2): C529C539.
  • Fan TP, Hu DE, Guard S, Gresham GA, Watling KJ. 1993. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. Br J Pharmacol 110(1): 4349.
  • Foreman JC. 1987. Substance P and calcitonin gene-related peptide: Effects on mast cells and in human skin. Int Arch Allergy Appl Immunol 82(3–4): 366371.
  • Gerard NP, Garraway LA, Eddy RL, Jr., Shows TB, Iijima H, Paquet JL, Gerard C. 1991. Human substance P receptor (NK-1): Organization of the gene, chromosome localization, and functional expression of cDNA clones. Biochemistry 30(44): 1064010646.
  • Germonpre PR, Bullock GR, Lambrecht BN, Van De Velde V, Luyten WH, Joos GF, Pauwels RA. 1999. Presence of substance P and neurokinin 1 receptors in human sputum macrophages and U-937 cells. Eur Respir J 14(4): 776782.
  • Goetzl EJ, Sreedharan SP. 1992. Mediators of communication and adaptation in the neuroendocrine and immune systems. FASEB J 6(9): 26462652.
  • Goode T, O'Connell J, Sternini C, Anton P, Wong H, O'Sullivan GC, Collins JK, Shanahan F. 1998. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: Molecular quantitation and localization. J Immunol 161(5): 22322240.
  • Goode T, O'Connell J, Anton P, Wong H, Reeve J, O'Sullivan GC, Collins JK, Shanahan F. 2000a. Neurokinin-1 receptor expression in inflammatory bowel disease: Molecular quantitation and localisation. Gut 47(3): 387396.
  • Goode T, O'Connell J, Ho WZ, O'Sullivan GC, Collins JK, Douglas SD, Shanahan F. 2000b. Differential expression of neurokinin-1 receptor by human mucosal and peripheral lymphoid cells. Clin Diagn Lab Immunol 7(3): 371376.
  • Goode T, O'Connor T, Hopkins A, Moriarty D, O'Sullivan GC, Collins JK, O'Donoghue D, Baird AW, O'Connell J, Shanahan F. 2003. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P. J Cell Physiol 197(1): 3041.
  • Grady EF, Yoshimi SK, Maa J, Valeroso D, Vartanian RK, Rahim S, Kim EH, Gerard C, Gerard N, Bunnett NW, Kirkwood KS. 2000. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol 130(3): 505512.
  • Gronblad M, Konttinen YT, Korkala O, Liesi P, Hukkanen M, Polak JM. 1988. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 15(12): 18071810.
  • Guo CJ, Lai JP, Luo HM, Douglas SD, Ho WZ. 2002. Substance P up-regulates macrophage inflammatory protein-1beta expression in human T lymphocytes. J Neuroimmunol 131(1–2): 160167.
  • Hadcock JR, Williams DL, Malbon CC. 1989. Physiological regulation at the level of mRNA: Analysis of steady-state levels of specific mRNAs by DNA-excess solution hybridization. Am J Physiol 256(3 Pt 1): C457C465.
  • Haines KA, Kolasinski SL, Cronstein BN, Reibman J, Gold LI, Weissmann G. 1993. Chemoattraction of neutrophils by substance P and transforming growth factor-beta 1 is inadequately explained by current models of lipid remodeling. J Immunol 151(3): 14911499.
  • Harrison NK, Dawes KE, Kwon OJ, Barnes PJ, Laurent GJ, Chung KF. 1995. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am J Physiol 268(2 Pt 1): L278L283.
  • Helke CJ, Krause JE, Mantyh PW, Couture R, Bannon MJ. 1990. Diversity in mammalian tachykinin peptidergic neurons: Multiple peptides, receptors, and regulatory mechanisms. FASEB J 4(6): 16061615.
  • Hershey AD, Krause JE. 1990. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 247(4945): 958962.
  • Hislop AA, Wharton J, Allen KM, Polak JM, Haworth SG. 1990. Immunohistochemical localization of peptide-containing nerves in human airways: Age-related changes. Am J Respir Cell Mol Biol 3(3): 191198.
  • Ho WZ, Kaufman D, Uvaydova M, Douglas SD. 1996. Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages. J Neuroimmunol 71(1–2): 7380.
  • Ho WZ, Lai JP, Zhu XH, Uvaydova M, Douglas SD. 1997. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J Immunol 159(11): 56545660.
  • Hokfelt T, Pernow B, Wahren J. 2001. Substance P: A pioneer amongst neuropeptides. J Int Med 249(1): 2740.
  • Holzer P, Holzer-Petsche U. 1997. Tachykinins in the gut. Part II. Roles in neural excitation, secretion, and inflammation. Pharmacol Ther 73(3): 219263.
  • Hong JL, Rodger IW, Lee LY. 1995. Cigarette smoke-induced bronchoconstriction: Cholinergic mechanisms, tachykinins, and cyclooxygenase products. J Appl Physiol 78(6): 22602266.
  • Hopkins B, Powell SJ, Danks P, Briggs I, Graham A. 1991. Isolation and characterisation of the human lung NK-1 receptor cDNA. Biochem Biophys Res Commun 180(2): 11101117.
  • Hunter DD, Myers AC, Undem BJ. 2000. Nerve growth factor-induced phenotypic switch in guinea pig airway sensory neurons. Am J Respir Crit Care Med 161(6): 19851990.
  • Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. 1992. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 340(8830): 12481251.
  • Ihara H, Nakanishi S. 1990. Selective inhibition of expression of the substance P receptor mRNA in pancreatic acinar AR42J cells by glucocorticoids. J Biol Chem 265(36): 2244122445.
  • Jacoby DB, Yost BL, Elwood T, Fryer AD. 2000. Effects of neurokinin receptor antagonists in virus-infected airways. Am J Physiol Lung Cell Mol Physiol 279(1): L59L65.
  • Joos GF. 2001. The role of neuroeffector mechanisms in the pathogenesis of asthma. Curr Allergy Asthma Rep 1(2): 134143.
  • Joos G, Pauwels R, van der Straeten M. 1987a. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 42(10): 779783.
  • Joos GF, Pauwels RA, Van der Straeten ME. 1987b. The role of neuropeptides as neurotransmitters of non-adrenergic, non-cholinergic nerves in bronchial asthma. Bull Eur Physiopathol Respir 23(6): 619637.
  • Joos GF, Pauwels RA, van der Straeten ME. 1988. The mechanism of tachykinin-induced bronchoconstriction in the rat. Am Rev Respir Dis 137(5): 10381044.
  • Joos GF, Kips JC, Pauwels RA. 1994. In vivo characterization of the tachykinin receptors involved in the direct and indirect bronchoconstrictor effect of tachykinins in two inbred rat strains. Am J Respir Crit Care Med 149(5): 11601166.
  • Joos GF, Germonpre PR, Pauwels RA. 2000. Role of tachykinins in asthma. Allergy 55(4): 321337.
  • Kage R, McGregor GP, Thim L, Conlon JM. 1988. Neuropeptide-gamma: A peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J Neurochem 50(5): 14121417.
  • Kahler CM, Sitte BA, Reinisch N, Wiedermann CJ. 1993. Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol 249(3): 281286.
  • Kaltreider HB, Ichikawa S, Byrd PK, Ingram DA, Kishiyama JL, Sreedharan SP, Warnock ML, Beck JM, Goetzl EJ. 1997. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Respir Cell Mol Biol 16(2): 133144.
  • Kang BN, Jeong KS, Park SJ, Kim SJ, Kim TH, Kim HJ, Ryu SY. 2001. Regulation of apoptosis by somatostatin and substance P in peritoneal macrophages. Regul Pept 101(1–3): 4349.
  • Karlsson JA. 1993. A role for capsaicin sensitive, tachykinin containing nerves in chronic coughing and sneezing but not in asthma: A hypothesis. Thorax 48(4): 396400.
  • Kataeva G, Agro A, Stanisz AM. 1994. Substance-P-mediated intestinal inflammation: Inhibitory effects of CP 96,345 and SMS 201-995. Neuroimmunomodulation 1(6): 350356.
  • Kaufman MP, Coleridge HM, Coleridge JC, Baker DG. 1980. Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol 48(3): 511517.
  • Keast JR, Furness JB, Costa M. 1985. Distribution of certain peptide-containing nerve fibres and endocrine cells in the gastrointestinal mucosa in five mammalian species. J Comp Neurol 236(3): 403422.
  • Killingsworth CR, Shore SA, Alessandrini F, Dey RD, Paulauskis JD. 1997. Rat alveolar macrophages express preprotachykinin gene-I mRNA-encoding tachykinins. Am J Physiol 273(5 Pt 1): L1073L1081.
  • Kim JS, Rabe KF, Magnussen H, Green JM, White SR. 1995. Migration and proliferation of guinea pig and human airway epithelial cells in response to tachykinins. Am J Physiol 269(1 Pt 1): L119L126.
  • Kimura M, Masuda T, Hiwatashi N, Toyota T, Nagura H. 1994. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathol Int 44(8): 624634.
  • King KA, Hu C, Rodriguez MM, Romaguera R, Jiang X, Piedimonte G. 2001. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats. Am J Respir Cell Mol Biol 24(2): 101107.
  • Koch TR, Carney JA, Go VL. 1987. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 32(4): 369376.
  • Kraneveld AD, Nijkamp FP. 2001. Tachykinins and neuro-immune interactions in asthma. Int Immunopharmacol 1(9–10): 16291650.
  • Krause JE, DiMaggio DA, McCarson KE. 1995. Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation. Can J Physiol Pharmacol 73(7): 854859.
  • Krco CJ, Gores A, Go VL. 1986. Gastrointestinal regulatory peptides modulate in vitro immune reactions of mouse lymphoid cells. Clin Immunol Immunopathol 39(2): 308318.
  • Kroegel C, Giembycz MA, Barnes PJ. 1990. Characterization of eosinophil cell activation by peptides. Differential effects of substance P, melittin, and FMET-Leu-Phe. J Immunol 145(8): 25812587.
  • Kuo HP, Rohde JA, Tokuyama K, Barnes PJ, Rogers DF. 1990. Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea-pig trachea. J Physiol 431: 629641.
  • Kuo HP, Hwang KH, Lin HC, Wang CH, Liu CY, Lu LC. 1998. Lipopolysaccharide enhances neurogenic plasma exudation in guinea-pig airways. Br J Pharmacol 125(4): 711716.
  • Kuo HP, Lin HC, Hwang KH, Wang CH, Lu LC. 2000. Lipopolysaccharide enhances substance P-mediated neutrophil adherence to epithelial cells and cytokine release. Am J Respir Crit Care Med 162(5): 18911897.
  • Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. 1993. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 148(5): 12201225.
  • Kuwano K, Miyazaki H, Hagimoto N, Kawasaki M, Fujita M, Kunitake R, Kaneko Y, Hara N. 1999. The involvement of Fas–Fas ligand pathway in fibrosing lung diseases. Am J Respir Cell Mol Biol 20(1): 5360.
  • Kwong K, Wu ZX, Kashon ML, Krajnak KM, Wise PM, Lee LY. 2001. Chronic smoking enhances tachykinin synthesis and airway responsiveness in guinea pigs. Am J Respir Cell Mol Biol 25(3): 299305.
  • Ladabaum U, Hasler WL. 1999. Novel approaches to the treatment of nausea and vomiting. Dig Dis 17(3): 125132.
  • Laitinen LA, Heino M, Laitinen A, Kava T, Haahtela T. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 131(4): 599606.
  • Lamb JP, Sparrow MP. 2002. Three-dimensional mapping of sensory innervation with substance P in porcine bronchial mucosa: Comparison with human airways. Am J Respir Crit Care Med 166(9): 12691281.
  • Lecci A, De Giorgio R, Bartho L, Sternini C, Tramontana M, Corinaldesi R, Giuliani S, Maggi CA. 1999. Tachykinin NK(1)receptor-mediated inhibitory responses in the guinea-pig small intestine. Neuropeptides 33(1): 9197.
  • Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI. 1984. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 226(4674): 547549.
  • Levine JD, Moskowitz MA, Basbaum AI. 1985. The contribution of neurogenic inflammation in experimental arthritis. J Immunol 135(2 Suppl):843s847s.
  • Li H, Leeman SE, Slack BE, Hauser G, Saltsman WS, Krause JE, Blusztajn JK, Boyd ND. 1997. A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization. Proc Natl Acad Sci USA 94(17): 94759480.
  • Lilly CM, Bai TR, Shore SA, Hall AE, Drazen JM. 1995a. Neuropeptide content of lungs from asthmatic and nonasthmatic patients. Am J Respir Crit Care Med 151(2 Pt 1): 548553.
  • Lilly CM, Hall AE, Rodger IW, Kobzik L, Haley KJ, Drazen JM. 1995b. Substance P-induced histamine release in tracheally perfused guinea pig lungs. J Appl Physiol 78(4): 12341241.
  • Lordal M, Hallgren A, Nylander O, Hellstrom PM. 1996. Tachykinins increase vascular permeability in the gastrointestinal tract of the rat. Acta Physiol Scand 156(4): 489494.
  • Lotz M, Carson DA, Vaughan JH. 1987. Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 235(4791): 893895.
  • Lotz M, Vaughan JH, Carson DA. 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241(4870): 12181221.
  • Lundberg JM, Saria A. 1983. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical, and chemical irritants. Nature 302(5905): 251253.
  • Lundberg JM, Martling CR, Saria A. 1983. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 119(1): 4953.
  • Maggi CA. 1990. Capsaicin-sensitive nerves in the gastrointestinal tract. Arch Int Pharmacodyn Ther 303: 157166.
  • Maggi CA. 1997. The effects of tachykinins on inflammatory and immune cells. Regul Pept 70(2–3): 7590.
  • Maggi CA. 2000. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul Pept 93(1–3): 5364.
  • Mantyh PW. 1991. Substance P and the inflammatory and immune response. Ann NY Acad Sci 632: 263271.
  • Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP, Jr., Vigna SR, Maggio JE, Kruger L, Mantyh PW. 1988. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 85(9): 32353239.
  • Mantyh CR, Vigna SR, Maggio JE, Mantyh PW, Bollinger RR, Pappas TN. 1994. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors. Neurosci Lett 178(2): 255259.
  • Mantyh CR, Maggio JE, Mantyh PW, Vigna SR, Pappas TN. 1996a. Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis. Dig Dis Sci 41(3): 614620.
  • Mantyh CR, Pappas TN, Lapp JA, Washington MK, Neville LM, Ghilardi JR, Rogers SD, Mantyh PW, Vigna SR. 1996b. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 111(5): 12721280.
  • Mapp CE, Miotto D, Braccioni F, Saetta M, Turato G, Maestrelli P, Krause JE, Karpitskiy V, Boyd N, Geppetti P, Fabbri LM. 2000. The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. Am J Respir Crit Care Med 161(1): 207215.
  • Marshall KW, Chiu B, Inman RD. 1990. Substance P and arthritis: Analysis of plasma and synovial fluid levels. Arthritis Rheum 33(1): 8790.
  • Martins MA, Shore SA, Drazen JM. 1991a. Capsaicin-induced release of tachykinins: Effects of enzyme inhibitors. J Appl Physiol 70(5): 19501956.
  • Martins MA, Shore SA, Drazen JM. 1991b. Release of tachykinins by histamine, methacholine, PAF, LTD4, and substance P from guinea pig lungs. Am J Physiol 261(6 Pt 1): L449L455.
  • Martling CR, Theodorsson-Norheim E, Lundberg JM. 1987. Occurrence and effects of multiple tachykinins: Substance P, neurokinin A, and neuropeptide K in human lower airways. Life Sci 40(16): 16331643.
  • Matis WL, Lavker RM, Murphy GF. 1990. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 94(4): 492495.
  • Matsumoto S, Takeda M, Saiki C, Takahashi T, Ojima K. 1997. Effects of tachykinins on rapidly adapting pulmonary stretch receptors and total lung resistance in anesthetized, artificially ventilated rabbits. J Pharmacol Exp Ther 283(3): 10261031.
  • Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR. 1999. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J Immunol 163(4): 22172225.
  • Mazumdar S, Das KM. 1992. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am J Gastroenterol 87(2): 176181.
  • McGowan IM, Fairhurst RM, Shanahan F, Anton PA. 1997. Mucosal substance P receptor expression in HIV infection and inflammatory bowel disease. Neuroimmunomodulation 4(2): 7076.
  • Menkes CJ, Renoux M, Laoussadi S, Mauborgne A, Bruxelle J, Cesselin F. 1993. Substance P levels in the synovium and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 20(4): 714717.
  • Metwali A, Blum AM, Ferraris L, Klein JS, Fiocchi C, Weinstock JV. 1994. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J Neuroimmunol 52(1): 6978.
  • Moore TC, Lami JL, Spruck CH. 1989. Substance P increases lymphocyte traffic and lymph flow through peripheral lymph nodes of sheep. Immunology 67(1): 109114.
  • Mousli M, Bueb JL, Bronner C, Rouot B, Landry Y. 1990. G protein activation: A receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci 11(9): 358362.
  • Murris-Espin M, Pinelli E, Pipy B, Leophonte P, Didier A. 1995. Substance P and alveolar macrophages: Effects on oxidative metabolism and eicosanoid production. Allergy 50(4): 334339.
  • Nadel JA. 1991. Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 4(6): 745754.
  • Nadel JA, Borson DB. 1991. Modulation of neurogenic inflammation by neutral endopeptidase. Am Rev Respir Dis 143(3 Pt 2): S33S36.
  • Nakagawa N, Sano H, Iwamoto I. 1995. Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides 16(4): 721725.
  • Nakanishi S. 1991. Mammalian tachykinin receptors. Annu Rev Neurosci 14: 123136.
  • Naukkarinen A, Harvima I, Paukkonen K, Aalto ML, Horsmanheimo M. 1993. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 285(6): 341346.
  • Nawa H, Kotani H, Nakanishi S. 1984. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature 312(5996): 729734.
  • Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. 1992. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 90(4 Pt 1): 646652.
  • Nilsson J, von Euler AM, Dalsgaard CJ. 1985. Stimulation of connective tissue cell growth by substance P and substance K. Nature 315(6014): 6163.
  • Nilsson G, Alving K, Ahlstedt S, Hokfelt T, Lundberg JM. 1990. Peptidergic innervation of rat lymphoid tissue and lung: Relation to mast cells and sensitivity to capsaicin and immunization. Cell Tissue Res 262(1): 125133.
  • Numao T, Agrawal DK. 1992. Neuropeptides modulate human eosinophil chemotaxis. J Immunol 149(10): 33093315.
  • O'Byrne EM, Blancuzzi V, Wilson DE, Wong M, Jeng AY. 1990. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum 33(7): 10231028.
  • O'Connor TM, O'Connell J, O'Brien DI, Bennett MW, Goode T, Bredin CP, Shanahan F. 2003. Upregulation of neurokinin-1 receptor expression in the lungs of patients with sarcoidosis. J Clin Immunol 23(5): 425435.
  • Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. 1991. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 4(6): 673682.
  • Pascual DW, Xu-Amano JC, Kiyono H, McGhee JR, Bost KL. 1991. Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J Immunol 146(7): 21302136.
  • Pauwels R, Joos G, Kips JC. 1993. The genetics of Asthma. In: MarshDG, LockhartA, HolgateST, editors. The genetic control of airway responsiveness in rats. Oxford: Blackwell Scientific Publications. pp 113120.
  • Pawlik WW, Konturek SJ, Gustaw P, Czarnobilski K, Sendur R, Jaworek J, Yanaihara N. 1992. Role of tachykinins in the control of pancreatic secretion and circulation. J Physiol Pharmacol 43(1): 4357.
  • Payan DG, Goetzl EJ. 1985. Modulation of lymphocyte function by sensory neuropeptides. J Immunol 135(2 Suppl):783s786s.
  • Perianin A, Snyderman R, Malfroy B. 1989. Substance P primes human neutrophil activation: A mechanism for neurological regulation of inflammation. Biochem Biophys Res Commun 161(2): 520524.
  • Pernow B. 1983. Substance P. Pharmacol Rev 35(2): 85141.
  • Piedimonte G, McDonald DM, Nadel JA. 1990. Glucocorticoids inhibit neurogenic plasma extravasation and prevent virus-potentiated extravasation in the rat trachea. J Clin Invest 86(5): 14091415.
  • Piedimonte G, Hoffman JI, Husseini WK, Snider RM, Desai MC, Nadel JA. 1993. NK1 receptors mediate neurogenic inflammatory increase in blood flow in rat airways. J Appl Physiol 74(5): 24622468.
  • Piedimonte G, Pickles RJ, Lehmann JR, McCarty D, Costa DL, Boucher RC. 1997. Replication-deficient adenoviral vector for gene transfer potentiates airway neurogenic inflammation. Am J Respir Cell Mol Biol 16(3): 250258.
  • Piedimonte G, Rodriguez MM, King KA, McLean S, Jiang X. 1999. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs. Am J Physiol 277(4 Pt 1): L831L840.
  • Pizzichini MM, Pizzichini E, Parameswaran K, Clelland L, Efthimiadis A, Dolovich J, Hargreave FE. 1999. Nonasthmatic chronic cough: No effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 6(4): 323330.
  • Pothoulakis C, Castagliuolo I, LaMont JT, Jaffer A, O'Keane JC, Snider RM, Leeman SE. 1994. CP-96,345: A substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc Natl Acad Sci USA 91(3): 947951.
  • Rameshwar P, Gascon P. 1995. Substance P (SP) mediates production of stem cell factor and interleukin-1 in bone marrow stroma: Potential autoregulatory role for these cytokines in SP receptor expression and induction. Blood 86(2): 482490.
  • Rameshwar P, Ganea D, Gascon P. 1993. In vitro stimulatory effect of substance P on hematopoiesis. Blood 81(2): 391398.
  • Rameshwar P, Poddar A, Zhu G, Gascon P. 1997. Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblasts. J Immunol 158(7): 34173424.
  • Repke H, Bienert M. 1987. Mast cell activation—a receptor-independent mode of substance P action? FEBS Lett 221(2): 236240.
  • Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A. 1993. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45(1): 87146.
  • Rosati R, Adil MR, Ali MA, Eliason J, Orosz A, Sebestyen F, Kalemkerian GP. 1998. Induction of apoptosis by a short-chain neuropeptide analog in small cell lung cancer. Peptides 19(9): 15191523.
  • Saban R, Nguyen N, Saban MR, Gerard NP, Pasricha PJ. 1999. Nerve-mediated motility of ileal segments isolated from NK(1) receptor knockout mice. Am J Physiol 277(6 Pt 1): G1173G1179.
  • Schratzberger P, Reinisch N, Prodinger WM, Kahler CM, Sitte BA, Bellmann R, Fischer-Colbrie R, Winkler H, Wiedermann CJ. 1997. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J Immunol 158(8): 38953901.
  • Scicchitano R, Biennenstock J, Stanisz AM. 1988. In vivo immunomodulation by the neuropeptide substance P. Immunology 63(4): 733735.
  • Serra MC, Bazzoni F, Della Bianca V, Greskowiak M, Rossi F. 1988. Activation of human neutrophils by substance P. Effect on oxidative metabolism, exocytosis, cytosolic Ca2+ concentration, and inositol phosphate formation. J Immunol 141(6): 21182124.
  • Shanahan F. 1993. Pathogenesis of ulcerative colitis. Lancet 342(8868): 407411.
  • Shanahan F, Denburg JA, Fox J, Bienenstock J, Befus D. 1985. Mast cell heterogeneity: Effects of neuroenteric peptides on histamine release. J Immunol 135(2): 13311337.
  • Sheldrick RL, Rabe KF, Fischer A, Magnussen H, Coleman RA. 1995. Further evidence that tachykinin-induced contraction of human isolated bronchus is mediated only by NK2-receptors. Neuropeptides 29(5): 281292.
  • Sheng M, Dougan ST, McFadden G, Greenberg ME. 1988. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol Cell Biol 8(7): 27872796.
  • Shore SA, Stimler-Gerard NP, Coats SR, Drazen JM. 1988. Substance P-induced bronchoconstriction in the guinea pig. Enhancement by inhibitors of neutral metalloendopeptidase and angiotensin-converting enzyme. Am Rev Respir Dis 137(2): 331336.
  • Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH. 1993. Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 151(6): 32743282.
  • Solway J, Leff AR. 1991. Sensory neuropeptides and airway function. J Appl Physiol 71(6): 20772087.
  • Solway J, Kao BM, Jordan JE, Gitter B, Rodger IW, Howbert JJ, Alger LE, Necheles J, Leff AR, Garland A. 1993. Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs. J Clin Invest 92(1): 315323.
  • Sonea IM, Palmer MV, Akili D, Harp JA. 2002. Treatment with neurokinin-1 receptor antagonist reduces severity of inflammatory bowel disease induced by Cryptosporidium parvum. Clin Diagn Lab Immunol 9(2): 333340.
  • Stanisz AM, Befus D, Bienenstock J. 1986. Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 136(1): 152156.
  • Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. 1987. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 84(9): 29752979.
  • Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. 1989. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97(3): 575585.
  • Strigas J, Burcher E. 1996. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands. Eur J Pharmacol 311(2–3): 177186.
  • Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N, Gerard C, Grady EF, Bunnett NW, Collins SM. 1999. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 96(20): 1165311658.
  • Swain MG, Agro A, Blennerhassett P, Stanisz A, Collins SM. 1992. Increased levels of substance P in the myenteric plexus of Trichinella-infected rats. Gastroenterology 102(6): 19131919.
  • Takebayashi T, Abraham J, Murthy GG, Lilly C, Rodger I, Shore SA. 1998. Role of tachykinins in airway responses to ozone in rats. J Appl Physiol 85(2): 442450.
  • Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE. 1991. Molecular cloning, structural characterization, and functional expression of the human substance P receptor. Biochem Biophys Res Commun 179(3): 12321240.
  • Takeyama M, Nagai S, Mori K, Ikawa K, Satake N, Izumi T. 1996. Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 13(1): 3337.
  • Tatemoto K, Lundberg JM, Jornvall H, Mutt V. 1985. Neuropeptide K: Isolation, structure, and biological activities of a novel brain tachykinin. Biochem Biophys Res Commun 128(2): 947953.
  • Tiberio IF, Turco GM, Leick-Maldonado EA, Sakae RS, Paiva SO, do Patrocinio M, Warth TN, Lapa e Silva JR, Saldiva PH, Martins MA. 1997. Effects of neurokinin depletion on airway inflammation induced by chronic antigen exposure. Am J Respir Crit Care Med 155(5): 17391747.
  • Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N, Shirato K. 1995. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 151(3 Pt 1): 613617.
  • Trautmann A, Schmid-Grendelmeier P, Kruger K, Crameri R, Akdis M, Akkaya A, Brocker EB, Blaser K, Akdis CA. 2002. T cells and eosinophils cooperate in the induction of bronchial epithelial cell apoptosis in asthma. J Allergy Clin Immunol 109(2): 329337.
  • Tripp RA, Barskey A, Goss L, Anderson LJ. 2002. Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection. J Neuroimmunol 129(1–2): 141153.
  • Uddman R, Hakanson R, Luts A, Sundler F. 1997. Autonomic Control of the Respiratory System. In: BarnesPJ, editor. Distribution of neuropeptides in airways. London: Harvard Academic.
  • Umeno E, Nadel JA, McDonald DM. 1990. Neurogenic inflammation of the rat trachea: Fate of neutrophils that adhere to venules. J Appl Physiol 69(6): 21312136.
  • Van Rensen EL, Hiemstra PS, Rabe KF, Sterk PJ. 2002. Assessment of microvascular leakage via sputum induction: The role of substance P and neurokinin A in patients with asthma. Am J Respir Crit Care Med 165(9): 12751279.
  • Van Schoor J, Joos GF, Pauwels RA. 2002. Effect of inhaled fluticasone on bronchial responsiveness to neurokinin A in asthma. Eur Respir J 19(6): 9971002.
  • Veronesi B, Carter JD, Devlin RB, Simon SA, Oortgiesen M. 1999. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line. Neuropeptides 33(6): 447456.
  • Vieira JE, Warth Mdo P, Leme AS, Maldonado EA, King M, Saldiva PH, Martins MA. 1997. Airway responses to capsaicin in guinea pigs: Role of NK-1 and NK-2 neurokinin receptors. Exp Lung Res 23(1): 8599.
  • Vishwanath R, Mukherjee R. 1996. Substance P promotes lymphocyte-endothelial cell adhesion preferentially via LFA-1/ICAM-1 interactions. J Neuroimmunol 71(1–2): 163171.
  • von Euler US, Gaddum JH. 1931. An unidentified depressor substance in certain tissue extracts. J Physiol (London) 72: 7487.
  • Weihe E, Nohr D, Michel S, Muller S, Zentel HJ, Fink T, Krekel J. 1991. Molecular anatomy of the neuro-immune connection. Int J Neurosci 59(1–3): 123.
  • Weinstock JV, Blum A, Walder J, Walder R. 1988. Eosinophils from granulomas in murine schistosomiasis mansoni produce substance P. J Immunol 141(3): 961966.
  • Wershil BK, Castagliuolo I, Pothoulakis C. 1998. Direct evidence of mast cell involvement in Clostridium difficile toxin A-induced enteritis in mice. Gastroenterology 114(5): 956964.
  • Wu ZX, Satterfield BE, Fedan JS, Dey RD. 2002. Interleukin-1beta-induced airway hyperresponsiveness enhances substance P in intrinsic neurons of ferret airway. Am J Physiol Lung Cell Mol Physiol 283(5): L909L917.
  • Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi CA. 1990. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 40(2): 264278.